Update shared on 14 Nov 2025
Fair value Decreased 0.15%Narrative Update on Masco: Analyst Price Target Adjustment
Analysts have slightly reduced their price target for Masco, lowering it from $73.78 to $73.67. This change reflects modest shifts in projected growth rates and profit margins.
What's in the News
- Masco completed the repurchase of 1,754,423 shares between July 1, 2025 and September 30, 2025, totaling $123.51 million and representing 0.84% of shares. This marks the completion of a broader buyback announced in October 2022, now totaling 21,313,934 shares, or 9.76% at a cost of $1,457.67 million (Key Developments).
- Masco provided earnings guidance for the full year ending December 31, 2025, projecting earnings per share in the range of $3.84 to $3.89 (Key Developments).
Valuation Changes
- Consensus Analyst Price Target has decreased marginally, from $73.78 to $73.67.
- Discount Rate has risen slightly, moving from 8.67% to 8.96%.
- Revenue Growth projections declined a bit, from 4.50% to 4.45%.
- Net Profit Margin forecasts edged down, from 12.45% to 12.42%.
- Future P/E ratio has increased modestly, from 16.24x to 16.39x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.